Monivent AB (XSAT:MONI) Other Stockholders Equity: kr7.22 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:MONI Monivent AB XSAT:MONI
26 GF Score
Price kr0.19
GF Value kr0.05
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Monivent AB Other Stockholders Equity?

Monivent AB XSAT:MONI +3.91% 26 Other Stockholders Equity is kr7.22 Mil as of Mar. 2026. GuruFocus rates XSAT:MONI with a GF Score™ of 26/100 and a GF Value™ of kr0.05 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Monivent AB's Other Stockholders Equity for the quarter that ended in Mar. 2026 was kr7.22 Mil.

Monivent AB's quarterly Other Stockholders Equity increased from Sep. 2025 (kr5.67 Mil) to Dec. 2025 (kr6.63 Mil) and increased from Dec. 2025 (kr6.63 Mil) to Mar. 2026 (kr7.22 Mil).

Monivent AB's annual Other Stockholders Equity increased from Dec. 2023 (kr3.90 Mil) to Dec. 2024 (kr4.11 Mil) and increased from Dec. 2024 (kr4.11 Mil) to Dec. 2025 (kr6.63 Mil).

Monivent AB Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Monivent AB's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Monivent AB Other Stockholders Equity Chart

Monivent AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only 5.16 4.49 3.90 4.11 6.63

Monivent AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.08 5.32 5.67 6.63 7.22
XSAT:MONI
26GF Score
Monivent AB XSAT:MONI
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Monivent AB Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of kr7.22 Mil mean?
Monivent AB (XSAT:MONI) has a Other Stockholders Equity of kr7.22 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Monivent AB and its competitors.
Is Monivent AB's Other Stockholders Equity too high?
Monivent AB's current Other Stockholders Equity is kr7.22 Mil. Overall, Monivent AB has a GF Score™ of 26/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Monivent AB's Other Stockholders Equity compare to ABT and SYK?
Monivent AB's Other Stockholders Equity of kr7.22 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Monivent AB and its competitors. Monivent AB's current Other Stockholders Equity is kr7.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Monivent AB stock overvalued right now?
Based on GuruFocus' analysis, Monivent AB (XSAT:MONI) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.05, compared to a current price of kr0.19 — trading 272% above its estimated fair value. The current Other Stockholders Equity is kr7.22 Mil. Monivent AB's overall GF Score™ is 26/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Monivent AB (XSAT:MONI), the current Other Stockholders Equity is kr7.22 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Monivent AB (XSAT:MONI) Overvalued in 2026?

Based on GuruFocus' analysis, Monivent AB stock appears to be overvalued. The current stock price of kr0.19 is trading 272% above its estimated GF Value™ of kr0.05. GuruFocus considers Monivent AB to be Significantly Overvalued.

Key valuation signals for XSAT:MONI:

  • Other Stockholders Equity: kr7.22 Mil
  • GF Value™: kr0.05 vs. price of kr0.19 (272% above fair value)
  • GF Score™: 26/100 with 5 warning signs

No single metric tells the full story. See the XSAT:MONI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Monivent AB Business Description

Address Regnbagsgatan 8B, Gothenburg, SWE, SE-417 55
Monivent AB is a medtech company focused on improving the care given to newborn babies in need of respiratory support at birth. The company has developed a patented solution that provides continuous feedback on the volumes of air given to the newborn during manual ventilation. The airflow is measured directly in the face mask and feedback on the ventilation parameters is displayed numerically and graphically in real-time on the external monitor. The company's product is Monivent Neo100.
26GF Score

Get the complete analysis for XSAT:MONI

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.19
Price
kr0.05
GF Value